Pavan Cheruvu Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Pavan Cheruvu.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Pavan Cheruvu. Pavan Cheruvu is Chief Executive Officer in Axovant Sciences Ltd. ($AXON) and Principal Executive Officer in Axovant Gene Therapies Ltd. ($AXON).
Latest Insider Trading Transactions of Pavan Cheruvu
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19 2021 | AXON | Sio Gene Therapies ... | Cheruvu Pavan | Chief Executive Off ... | Option Exercise | A | 2.47 | 682,100 | 1,684,787 | 682,100 | |
| Apr 19 2021 | AXON | Sio Gene Therapies ... | Cheruvu Pavan | Chief Executive Off ... | Option Exercise | A | 2.47 | 682,100 | 1,684,787 | 682,100 | |
| Mar 24 2021 | AXON | Sio Gene Therapies ... | Cheruvu Pavan | Chief Executive Off ... | Buy | P | 2.48 | 100,000 | 248,180 | 180,426 | 80.4 K to 180.4 K (+124.34 %) |
| Mar 19 2021 | AXON | Sio Gene Therapies ... | Cheruvu Pavan | Chief Executive Off ... | Option Exercise | D | 0.00 | 22,590 | 0 | 0 | |
| Mar 19 2021 | AXON | Sio Gene Therapies ... | Cheruvu Pavan | Chief Executive Off ... | Grant | A | 0.00 | 22,590 | 0 | 80,426 | 57.8 K to 80.4 K (+39.06 %) |
| Jul 10 2020 | AXON | Axovant Gene Thera ... | Cheruvu Pavan | Principal Executive ... | Buy | P | 2.74 | 37,500 | 102,638 | 57,836 | 20.3 K to 57.8 K (+184.40 %) |
| Jun 15 2020 | AXON | Axovant Gene Thera ... | Cheruvu Pavan | Principal Executive ... | Option Exercise | D | 0.00 | 22,591 | 0 | 22,590 | |
| Jun 15 2020 | AXON | Axovant Gene Thera ... | Cheruvu Pavan | Principal Executive ... | Payment of Exercise | F | 3.09 | 9,755 | 30,143 | 20,336 | 30.1 K to 20.3 K (-32.42 %) |
| Jun 15 2020 | AXON | Axovant Gene Thera ... | Cheruvu Pavan | Principal Executive ... | Grant | A | 0.00 | 22,591 | 0 | 30,091 | 7.5 K to 30.1 K (+301.21 %) |
| Apr 17 2020 | AXON | Axovant Gene Thera ... | Cheruvu Pavan | Principal Executive ... | Option Exercise | A | 0.00 | 112,700 | 0 | 112,700 | |
| Apr 17 2020 | AXON | Axovant Gene Thera ... | Cheruvu Pavan | Principal Executive ... | Option Exercise | A | 3.45 | 169,100 | 583,395 | 169,100 | |
| Sep 24 2019 | AXON | Axovant Gene Thera ... | Cheruvu Pavan | Principal Executive ... | Option Exercise | A | 0.00 | 45,181 | 0 | 45,181 | |
| Jun 17 2019 | AXON | Axovant Gene Thera ... | Cheruvu Pavan | Chief Executive Off ... | Buy | P | 5.21 | 7,500 | 39,075 | 7,500 | 0 to 7.5 K |
| Apr 17 2019 | AXON | Axovant Sciences L ... | Cheruvu Pavan | Chief Executive Off ... | Option Exercise | A | 1.06 | 1,596,000 | 1,691,760 | 1,596,000 | |
| Apr 17 2019 | AXON | Axovant Sciences L ... | Cheruvu Pavan | Chief Executive Off ... | Option Exercise | A | 1.06 | 1,596,000 | 1,691,760 | 1,596,000 | |
| Feb 15 2018 | AXON | Axovant Sciences L ... | Cheruvu Pavan | Chief Executive Off ... | Option Exercise | A | 1.81 | 1,940,185 | 3,511,735 | 1,940,185 |
Page: 1